Karen Valentine, VP and General Counsel at ANTIGENICS INC /DE/ (AGEN), sold 2,500 shares at $0.98 ($2K) on 2010-10-27, disclosed to the SEC on 2010-10-28.
Scheduled sale ($2k) by VP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNST | SELL | 2020-04-29 | $16K | — | Filing → |
| CNST | SELL | 2020-04-22 | $27K | — | Filing → |
| CNST | SELL | 2020-04-20 | $247K | — | Filing → |